Six months’ treatment with MIV-711, a novel Cathepsin K inhibitor induces osteoarthritis structure modification: results from a randomized double-blind placebo-controlled phase IIA trial

Autor:	Conaghan, P.G. †, Bowes, M.A. ‡, Kingsbury, S.R. †, Brett, A. ‡, Guillard, G. ‡, Tunblad, K. §, Rizoska, B. §, Larsson, T. §, Holmgren, Å. §, Manninen, A. §, Göhlin, K. §, Heber, W. ‖, Graham, P. §, Jansson, Å. §, Wadell, C. §, Bethell, R. §, Öhd, J. §
Zdroj:	In Osteoarthritis and Cartilage April 2018 26 Supplement 1:S25-S26
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect